Cat. No. 3744

RVD-Hpa Arg-Val-Asp-Pro-Val-Asn-Phe-Lys-Leu-Leu-Ser-His

Price and Availability

For RVD-Hpα pricing & availability please select your country from the drop down menu:
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Biological Activity

N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. Increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro.

Technical Data

Soluble to 1 mg/ml in 20% acetonitrile / water
Store at -20°C

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet


Gomes et al (2009) Novel endogenous peptide agonists of cannabinoid receptors. FASEB J. 23 3020. PMID: 19380512.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

View Related Products by Product Action

Keywords: RVD-Hpa, supplier, selective, CB1, receptors, agonists, cannabinoids, RVD-Hpalpha, RVD-Hpα, cb1r, CB1 Receptor Agonists

Quick Order

Find multiple products by catalog number

divider line

Pain Research Product Guide

Pain Research Product Guide

Highlights over 280 products for Pain research. Request copy or view PDF today.

divider line

Neurodegeneration Research Product Guide

Neurodegeneration Product Guide

Updated in 2015, this guide highlights over 275 products for neurodegeneration research. Request copy or view PDF today.

divider line

Cannabinoid Review

Cannabinoid Receptor Ligands Scientific Review

Written by Roger Pertwee, an expert. Request copy or view PDF today.

divider line

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

Schizophrenia Life Science Poster

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development. Request copy today.

divider line

New Products in this Area

AM 6545

High affinity and selective CB1 antagonist

ML 193

Potent, selective GPR55 antagonist

Sign-up for new product e-alerts
divider line

Bio-Techne Events

ASCB 2015

ASCB 2015

December 12 - 16, 2015

San Diego, CA